FDA Issues Final Guidance on Enforcement Discretion for In Vitro Diagnostic Tests in Declared Emergencies
September 23, 2025 On September [...]
FDA Officially Rescinds the LDT Final Rule
September 19, 2025 On September [...]
A New Chapter in U.S. Nicotine Policy: Kennedy Signals Shift Toward Tobacco Harm Reduction
July 31, 2025 The U.S. [...]
Accorto’s Perspective: FDA’s JUUL Decision Signals Path Forward for Committed Applicants
July 24, 2025 We are [...]
JUUL Labs’ Statement On FDA Marketing Authorizations
The Following Press Release Was Provided by JUUL Labs [...]
FDA Pauses Overseas Genetic Engineering Trials: What It Means for the Industry
June 19, 2025 On June [...]
Modernizing U.S. Cosmetic Regulation: A Guide to MoCRA
June 20, 2025 The Modernization [...]
Understanding Medical Device Classifications: A Guide for Medical Device Innovators and Manufacturers
May 13, 2025 When beginning [...]
PMTA vs. STN: Understanding the Regulatory Process for Nicotine Products
April 23, 2025 | Expert Insights [...]
Understanding the Regulatory Framework for OTC Drugs in the United States
April 9, 2025 Over-the-counter (OTC) [...]
